Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV randomized open-label study of beinaglutide versus biphasic insulin aspart 30 in adults with type 2 diabetes inadequately controlled on metformin
CTR20171296Phase 4Active
- Sponsor
- RemeGen
- Start
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of beinaglutide in type 2 diabetes mellitus (T2DM), sponsored by RemeGen. Started Apr 2018; status: active.
02
Drugs
beinaglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20171296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171296.